Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1353-1355

  Choung, Bum Su ^a   Yoo, Wan Hee ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

IV immunoglobulin; Pancytopenia; Primary Sj gren's syndrome; Thrombocytopenia

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISOLONE;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; HUMAN; PANCYTOPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PURPURA; REMISSION; SJOEGREN SYNDROME; THERAPY EFFECT; THROMBOCYTOPENIA;

ADULT; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; PANCYTOPENIA; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84863625989     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1395-4     Document Type: Article

References (20)

1. Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS, Frank MM, Lawley TJ, Hamburger MI (1980) Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med 92(2):212-226
2. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89(6):888-892
3. Asmussen K, Andersen V, Bendixen G, Schiødt M, Oxholm P (1996) A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study. J Intern Med 239(6):475-482
4. Seki T, Kiyosawa K, Monno S, Imai Y, Furukawa K, Kumazawa S, Ota M, Saito H, Furuta S, Nakahata T (1993) Cell-mediated immune-pancytopenia complicating primary Sjögren's syndrome. Am J Hematol 43(3):221-225
5. Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GR (1985) Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol 59(2):227-230
6. Ramakrishna R, Chaudhuri K, Sturgess A, Manoharan A (1992) Haematological manifestations of primary Sjögren's syndrome: a clinicopathological study. Q J Med 83(303):547-554
7. Lamour A, Le Corre R, Pennec YL, Cartron J, Youinou P (1995) Heterogeneity of neutrophil antibodies in patients with primary Sjögren's syndrome. Blood 86(9):3553-3559
8. Henriksson G, Manthorpe R, Bredberg A (2000) Antibodies to CD4 in primary Sjögren's syndrome. Rheumatology (Oxford) 39(2):142-147
9. Fox RI, Howell FV, Bone RC, Michelson P (1984) Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum 14(2):77-105
10. Aoki A, Ohno S, Ueda A, Ideguchi H, Ohkubo T, Hagiwara E, Shirai A, Oketani M, Nagaoka S, Senuma A, Ohota S, Matsunaga K, Ishigatsubo Y (2000) Hematological abnormalities of primary Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 23(2):124-128
11. Sugai S, Tachibana J, Shimizu S, Konda S (1989) Thrombocy-topenia in patients with Sjögren's syndrome. Arthritis Rheum 32(2):234-235
12. Schattner A, Friedman J, Klepfish A, Berrebi A (2000) Immune cytopenias as the presenting finding in primary Sjögren's syndrome. QJM 93(12):825-829
13. Kamimura T, Sato H, Iwamoto M, Nara H, Torikoe K, Masuyama J, Okazaki H, Minota S (2005) Sjögren's syndrome associated with chronic hepatitis C, severe thrombocytopenia, hypertrophic cardiomyopathy, and diabetes mellitus. Intern Med 44(6):657-661
14. Haro T, Shimoike E, Horiuchi T, Maruyama T, Niho Y (2000) Severe thrombocytopenia caused by digitoxin intoxication in a patient with heart failure associated with Sjögren's syndrome. Jpn Circ J 64(4):309-311
15. Pyne D, Ehrenstein M, Morris V (2002) The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology (Oxford) 41(4):367-374
16. Durez P, Tourne L, Feremans W, Mascart-Lemone F, Heenen M, Appelboom T (1998) Dramatic response to intravenous high dose gamma-globulin in refractory vasculitis of the skin associated with Sjogren's syndrome. J Rheumatol 25(5):1032-1033
17. Mochizuki H, Kamakura K, Masaki T, Hirata A, Nakamura R, Motoyoshi K (2002) Motor dominant neuropathy in Sjogren's syndrome: report of two cases. Intern Med 41(2):142-146
18. Dupond JL, Gil H, de Wazieres B (1999) Five-year efficacy of intravenous gammaglobulin to treat dysautonomia in Sjogren's syndrome. Am J Med 106(1):125
19. Molina JA, Benito-Leon J, Bermejo F, Jimenez-Jimenez FJ, Olivan J (1996) Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjogren's syndrome. J Neurol Neu-rosurg Psychiatry 60(6):699
20. Canhao H, Fonseca JE, Rosa A (2000) Intravenous gamma-globulin in the treatment of central nervous system vasculitis associated with Sjogren's syndrome. J Rheumatol 27(4):1102-1103